The Effects of Levcromakalim in Patients With Cluster Headache

Status Completed

Clinical Trial Summary

Cluster headache is a primary headache disorder characterized by attacks of unilateral headache of short duration and severe pain intensity. There is an unmet need to understand the underlying disease mechanisms that will ultimately lead to the development of disease-specific medicines. Until now, it has been suggested that the calcitonin gene-related peptide (CGRP) plays a major role in the initiation of a cluster headache attack, possibly involving the ATP-sensitive potassium channels. The current study aims to determine whether the opening of ATP-sensitive potassium channels triggers cluster headache attacks in patients with cluster headache.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05093582
Study type	Interventional
Source	Danish Headache Center
Contact
Status	Completed
Phase	N/A
Start date	June 4, 2021
Completion date	September 27, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05264714` - Cluster Headache Treatment With Rimegepant	Phase 2
Completed	`NCT01677026` - Data Collection on the ATI Neurostimulation System: SPG Stimulation for Cluster Headache
Terminated	`NCT00203190` - A Double-Blind, Placebo-Controlled Study Examining the Use of Topiramate in the Treatment of Cluster Headache	Phase 4
Terminated	`NCT04570475` - High Dose Vitamin D Plus Multivitamin in the Prevention of Cluster Headache	Phase 3
Completed	`NCT04066023` - Double-Blind Comparison of the Efficacy and Safety of C213 to Placebo for the Acute Treatment of Cluster Headaches	Phase 2/Phase 3
Withdrawn	`NCT04353505` - Intra-arterial Sphenopalatine Ganglion Block for Patients With Refractory Headache	Phase 1
Completed	`NCT02019017` - Botox Injection in Treatment of Cluster Headache	Phase 1/Phase 2
Completed	`NCT05153876` - An Open Internet-based Survey and Natural Language Processing Project Analysing Written Monologues by Headache Patients
Recruiting	`NCT05324748` - Repeated GON Injections in CCH	Phase 3
Completed	`NCT02782533` - DBS of the Third Ventricle for Cluster Headache and Obesity	N/A
Completed	`NCT04179266` - Effect of Ketamine Intranasal Spray in Treatment of Chronic Cluster Headache	Phase 1/Phase 2
Recruiting	`NCT04406259` - Atrioventricular Block and Cluster Headache (SEVA)	Phase 4
Recruiting	`NCT06206772` - Resting State Functional Connectivity in Cluster Headache
Recruiting	`NCT03944876` - Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Cluster Headache	Phase 3
Not yet recruiting	`NCT05857098` - Detection of Local Field Potentials in the Ventral Tegmental Area of the Midbrain in Chronic Cluster Headache Patients
Recruiting	`NCT02910323` - The Will Erwin Headache Research Center - Cluster Headache Study
Terminated	`NCT00458770` - Study of Hypothalamic Metabolism in Spontaneous Cluster Headache Attacks	N/A
Completed	`NCT00662935` - Evaluation of Efficacity and Safety of Deep Brain Stimulation (DBS) in Chronic and Treatment-Resistant Cluster Headache(CH)	N/A
Active, not recruiting	`NCT03511846` - Pain Biomarker Study	Phase 1
Completed	`NCT00184587` - Prophylactic Treatment of Episodic Cluster Headache	Phase 2